BDR yields 655.74% · ABBV yields 3.06%● Live data
📍 BDR pulled ahead of the other in Year 1
Combined, BDR + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BDR + ABBV for your $10,000?
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders. The company also provides NXG IP digital video processing and headend products, including IPTV format conversions and simulcast use cases. In addition, it offers coax distribution products comprising broadband amplifiers, directional taps, splitters, and wall outlets; coax distribution products are either mounted on exterior utility poles or encased in pedestals, vaults, or other security devices in cable television systems; distribution system is enclosed within the walls of the building or added to an existing structure using various techniques to hide the coax cable and devices in SMB systems; and non-passive devices for signal distributed from the headend is of sufficient strength when it arrives at its final destination to provide audio/video images. Further, the company provides CPE products consisting of Android-based IPTV set top boxes. Additionally, it offers digital modulation products, such as Aircastertm ATSC, QAM, and IP trans-modulator series of products allow the user to create a line up from off-air and/or cable feeds for coax IP distribution; Edge QAM devices that accept Ethernet input and capture MPEG over IP transport streams, decrypt service provider conditional access or content protection, and insert proprietary conditional access; DOCSIS data products; service level agreements and services; and analog modulation, fiber, and miscellaneous products and services, as well as test and measurement instruments, and contract manufacturing services. The company was founded in 1950 and is headquartered in Old Bridge, New Jersey.
Full BDR Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.